[go: up one dir, main page]

CA2328138A1 - Technique de diagnostic, de suivi et de stadification du cancer du poumon - Google Patents

Technique de diagnostic, de suivi et de stadification du cancer du poumon Download PDF

Info

Publication number
CA2328138A1
CA2328138A1 CA002328138A CA2328138A CA2328138A1 CA 2328138 A1 CA2328138 A1 CA 2328138A1 CA 002328138 A CA002328138 A CA 002328138A CA 2328138 A CA2328138 A CA 2328138A CA 2328138 A1 CA2328138 A1 CA 2328138A1
Authority
CA
Canada
Prior art keywords
lsg
levels
cancer
lung
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002328138A
Other languages
English (en)
Inventor
Fei Yang
Roberto A. Macina
Yongming Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2328138A1 publication Critical patent/CA2328138A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne une technique permettant de faire la détection, le diagnostic, le suivi, la stadification et le progonostic du cancer du poumon.
CA002328138A 1998-05-21 1999-05-12 Technique de diagnostic, de suivi et de stadification du cancer du poumon Abandoned CA2328138A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8621298P 1998-05-21 1998-05-21
US60/086,212 1998-05-21
PCT/US1999/010344 WO1999060160A1 (fr) 1998-05-21 1999-05-12 Technique de diagnostic, de suivi et de stadification du cancer du poumon

Publications (1)

Publication Number Publication Date
CA2328138A1 true CA2328138A1 (fr) 1999-11-25

Family

ID=22197037

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002328138A Abandoned CA2328138A1 (fr) 1998-05-21 1999-05-12 Technique de diagnostic, de suivi et de stadification du cancer du poumon

Country Status (4)

Country Link
EP (1) EP1082459A4 (fr)
JP (1) JP3688585B2 (fr)
CA (1) CA2328138A1 (fr)
WO (1) WO1999060160A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030130182A1 (en) * 1997-11-05 2003-07-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7160679B1 (en) 1998-05-21 2007-01-09 Diadexus, Inc. Method of diagnosing, monitoring, and staging lung cancer
US7291712B2 (en) 1998-06-25 2007-11-06 Genentech, Inc. Interleukin-8 homologous polypeptides and therapeutic uses thereof
EP1104486A4 (fr) * 1998-08-04 2002-07-17 Diadexus Llc Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons
CA2341142A1 (fr) * 1998-09-02 2000-03-09 Diadexus Llc Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement de divers cancers
US20020004206A1 (en) * 1999-04-09 2002-01-10 Berger Barry M. Methods of screening for disease
CA2366778C (fr) 1999-04-09 2008-07-22 Exact Sciences Corporation Procedes de detection d'acides nucleiques revelateurs de cancer
US20030211510A1 (en) 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
EP1259545A2 (fr) 2000-01-21 2002-11-27 Ludwig Institute For Cancer Research Antigenes associes au cancer du poumon a petites cellules et utilisations de ces antigenes
US20030049617A1 (en) * 2000-02-17 2003-03-13 Sei-Yu Chen Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
AU2001251084A1 (en) * 2000-03-29 2001-10-08 Diadexus, Inc. Polynucleotides and polypeptides as well as methods for diagnosing and treating lung cancer
AU2001277937A1 (en) * 2000-07-21 2002-02-05 Diadexus, Inc. Compositions and methods relating to lung specific genes
US20030017468A1 (en) * 2000-08-28 2003-01-23 Sei-Yu Chen Compositions and methods relating to lung specific genes
EP1356038A2 (fr) * 2000-10-26 2003-10-29 Diadexus, Inc. Compositions et procedes associes aux genes et aux proteines specifiques du poumon
WO2002068633A2 (fr) * 2000-11-22 2002-09-06 Diadexus, Inc. Compositions et procedes concernant des genes et proteines specifiques aux poumons
EP1873245A1 (fr) * 2001-02-28 2008-01-02 Genentech, Inc. Polypeptides homologue à l'interleukine-8 et utilisations thérapeutiques correspondantes
US7332590B2 (en) 2001-08-16 2008-02-19 The United States Of America As Represented By The Department Of Health And Human Services Molecular characteristics of non-small cell lung cancer
DE10254601A1 (de) * 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
WO2006013012A2 (fr) * 2004-08-04 2006-02-09 Bayer Healthcare Ag Diagnostics et therapeutique pour maladies liees a la napsine 1 (nap1)
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
EP1874962A2 (fr) 2005-04-14 2008-01-09 The Trustees Of Boston University Diagnostic des troubles pulmonaires mettant en oeuvre la prediction de categories
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
EP2605018A1 (fr) 2006-03-09 2013-06-19 The Trustees of the Boston University Procédés de diagnostic et de pronostic pour troubles pulmonaires à l'aide de profils d'expression génique à partir de cellules épithéliales nasales
CN101990577A (zh) 2007-09-19 2011-03-23 波士顿大学理事会 鉴定肺病药物开发的新途径
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
JP6078339B2 (ja) 2009-05-07 2017-02-08 ベラサイト インコーポレイテッド 甲状腺状態の診断のための方法および組成物
US10526655B2 (en) 2013-03-14 2020-01-07 Veracyte, Inc. Methods for evaluating COPD status
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
EP3770274A1 (fr) 2014-11-05 2021-01-27 Veracyte, Inc. Systèmes et procédés de diagnostic de la fibrose pulmonaire idiopathique sur des biopsies transbronchiques à l'aide de l'apprentissage automatique et de données de transcription dimensionnelle élevée
US10927417B2 (en) 2016-07-08 2021-02-23 Trustees Of Boston University Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039419A1 (fr) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Genes et proteines specifiques du colon
US5939265A (en) * 1996-11-05 1999-08-17 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
JP2001522225A (ja) * 1997-01-31 2001-11-13 アボツト・ラボラトリーズ 肺の疾患の検出に有用な試薬及び方法
US6203979B1 (en) * 1998-01-16 2001-03-20 Incyte Pharmaceuticals, Inc. Human protease molecules
EP1090118A2 (fr) * 1998-06-26 2001-04-11 Incyte Pharmaceuticals, Inc. Proteines contenant un peptide signal humain

Also Published As

Publication number Publication date
JP2002515262A (ja) 2002-05-28
WO1999060160A1 (fr) 1999-11-25
EP1082459A4 (fr) 2002-09-25
JP3688585B2 (ja) 2005-08-31
EP1082459A1 (fr) 2001-03-14

Similar Documents

Publication Publication Date Title
CA2328138A1 (fr) Technique de diagnostic, de suivi et de stadification du cancer du poumon
CN107326066B (zh) 用于膀胱癌检测的尿标记物
EP1080227B1 (fr) Procédé de diagnostic, de surveillance et de détermination du stade du cancer du colon
CA2341142A1 (fr) Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement de divers cancers
US6228596B1 (en) Method of detecting and monitoring endometrial and uterine cancers
US20060035292A1 (en) Differential diagnosis of cancer and other conditions based on expression of p63
EP1270745A2 (fr) Thymosin B15 comme marqueur dans le diagnostic et prognostic de cancer
JP3524061B2 (ja) 肺がんを診断し、モニターし、病期決定し、画像化し、そして処置する新規な方法
JP3677210B2 (ja) 前立腺がんを診断し、モニターし、そして病期決定する新規な方法
JP2002525031A (ja) 大腸癌の診断、監視、病期決定、画像処理及び治療の新規方法
US6949339B1 (en) Method of diagnosing, monitoring, and staging colon cancer
AU2020200168A1 (en) Urine markers for detection of bladder cancer
US20100167278A1 (en) Novel Method of Diagnosing, Monitoring, and Staging Prostate Cancer
US7160679B1 (en) Method of diagnosing, monitoring, and staging lung cancer
US7713693B1 (en) Human cancer cell specific gene transcript
JP2002526760A (ja) 消化器癌を診断、監視、病期分類、イメージング及び治療する新規な方法
JP2002526055A (ja) 婦人科癌及び精巣癌を診断、監視、病期分類、イメージング及び治療する方法
US6379893B1 (en) Evaluation of adenocarcinoma of the prostate and breast using anti-dystroglycan antibodies
EP1621639A2 (fr) Nouveau procédé de diagnostic, de surveillance et de stadification du cancer de la prostate
KR20230119346A (ko) 흑색종 치료 내성 예측용 trim51 바이오마커 및 이의 용도
HK1108466B (en) Urine markers for detection of bladder cancer
HK1108466A (en) Urine markers for detection of bladder cancer

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead